Cite
HARVARD Citation
Liou, J. et al. (2023). Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. Lancet gastroenterology and hepatology. pp. 228-241. [Online].